Skip to main content

Find Clinical Trials

Home
Conditions
Neoplasms With Mesothelin Expression

Clinical trial condition

Neoplasms With Mesothelin Expression

Explore clinical trials studying Neoplasms With Mesothelin Expression. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms With Mesothelin Expression trial results

Completed

Mesothelin-Targeted Immunotoxin LMB-100 in Combination With Tofacitinib in Persons With Previously Treated Pancreatic Adenocarcinoma, Cholangiocarcinoma and Other Mesothelin Expressing Solid Tumors

NCT04034238

Conditions: Adenocarcinoma, Adenocarcinoma, Pancreatic, Carcinoma, +7 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details